With the Nasdaq at record highs, these are the benchmark's most beloved stocks that are expected to rally
[ad_1] Even as the Nasdaq Composite is surging to new highs, investors can still find stocks within the index that
Read More
Moderna Inc
Stocks making the biggest moves midday: Berkshire Hathaway, R1 RCM, Freshpet, Amer Sports and more
[ad_1] Check out the companies making headlines in midday trading. Berkshire Hathaway — Berkshire’s Class B shares dipped 1.2% in
Read More
Monday's analyst calls: Cloud stock to rally nearly 30%, Covid vaccine maker gets downgrade
[ad_1] (This is CNBC Pro’s live coverage of Monday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes
Read More
Stocks making the biggest moves midday: Nvidia, Rivian, Moderna, Novavax and more
[ad_1] Check out the companies making headlines in midday trading. Nvidia — The chipmaker giant rallied 15% after posting a
Read More
Nvidia earnings, Fed minutes on deck next week as Wall Street assesses interest rate outlook
[ad_1] Wall Street’s biggest AI darling is about to report earnings next week, and the results may show whether the
Read More
Phillippe Laffont's Coatue shifted money in technology amid fourth quarter rally
[ad_1] Phillippe Laffont’s Coatue made a flurry of changes to his portfolio in the fourth quarter, including shifts within the
Read More
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
[ad_1] Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January
Read More
Jim Cramer reviews the worst performers on the Nasdaq-100 in 2023
[ad_1] CNBC’s Jim Cramer on Thursday gave his take on the worst performers in the Nasdaq-100 in 2023. Cramer compared
Read More
CNBC Daily Open: A disappointing start to the year, but long-term view’s still bright
[ad_1] Traders work on the floor of the New York Stock Exchange (NYSE) on the first trading day of 2024
Read More
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
[ad_1] Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer
Read More